Synonym: 1-butanoyl-lysergic acid diethylamide hemi-L-tartrate
CAS Number: 2349376-12-9
Formula: (8β)-1-butanoyl-N,N-diethyl-6-methyl-9,10-didehydroergoline-8- carboxamide hemi-L-tartrate
Molar mass: 468.5 g/mol
Purity: >97%
Price range: $8 through $496
1B-LSD is a synthetic compound belonging to the lysergamide family. Structurally, it is closely related to LSD (lysergic acid diethylamide), a well-known psychedelic substance. However, 1B-LSD is specifically designed for research purposes to study its psychoactive properties. Importantly, 1B-LSD is not suitable for human consumption and should only be handled in controlled environments by qualified researchers.
To explore a variety of lysergamides, visit Medeus Research Chem Lysergamides.
The development of 1B-LSD stems from the continuous exploration of new compounds in scientific laboratories. Chemists utilize chemical synthesis to combine specific precursor materials and create 1B-LSD through a series of carefully controlled reactions and purification processes.
This compound has gained attention due to its potential for advancing scientific understanding of psychoactive substances. Researchers are particularly focused on its interaction with serotonin receptors, which play a critical role in mood regulation, sensory perception, and cognitive functions.
For a comprehensive range of research chemicals, check out Medeus Research Chem.
1B-LSD 125 MCG blotters are part of the lysergamide family and are a derivative of LSD. While they share structural similarities, 1B-LSD is distinguished by the addition of a butanoyl group at the 1-position, making it unique from its parent compound.
Researchers value the consistency and purity of 1B-LSD blotters, which are essential for obtaining accurate experimental results.
Research into 1B-LSD suggests that it interacts with serotonin receptors in the brain. This interaction may lead to:
However, the pharmacological profile of 1B-LSD is still not fully understood. Ongoing studies aim to uncover its therapeutic potential and its effects on cognitive processes.
Explore related products at Medeus Research Chem and K2 Infused Paper.
Proper handling and administration are critical when working with 1B-LSD 125 MCG blotters. Researchers are encouraged to:
Each blotter should be handled with precision to maintain the integrity of the research.
The creation of 1B-LSD is rooted in the quest to better understand the pharmacological and psychoactive properties of lysergamides. By synthesizing this compound, scientists aim to study its mechanisms of action and its potential therapeutic applications.
The compound’s interaction with serotonin receptors, which influence mood and sensory perception, makes it a valuable tool for research into neurochemical processes.
Discover the forefront of research advancements at K2 Legal High Incense.
For pricing and availability of 1B-LSD 125 MCG blotters, contact our customer support team or visit our website. We are committed to:
Start your research journey by visiting Medeus Research Chem.
Q: Is 1B-LSD legal?
A: The legal status of 1B-LSD varies by region. Always consult your local laws before purchasing or handling this compound.
Q: What makes 1B-LSD different from LSD?
A: 1B-LSD has a butanoyl group at the 1-position, distinguishing it structurally from LSD and potentially altering its pharmacological profile.
Q: Can 1B-LSD be consumed by humans?
A: No, 1B-LSD is strictly for research purposes and unsuitable for human consumption.
Q: Where can I buy 1B-LSD?
A: Visit Medeus Research Chem to inquire about 1B-LSD 125 MCG blotters and explore related products.
1B-LSD represents a significant advancement in the study of psychoactive substances. Its unique structure and interaction with serotonin receptors offer researchers a valuable tool for exploring cognitive processes and potential therapeutic applications.
To order high-quality 1B-LSD 125 MCG blotters and support your scientific research, visit Medeus Research Chem. Unlock the possibilities of this fascinating compound and join the scientific community at the forefront of discovery.